Tempest Therapeutics TPST
NASDAQ TPST
$0.81 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Asset Writedowns and Impairment (2016 - 2017)

Updated

Tempest Therapeutics' Asset Writedowns and Impairment came in at $172,000 for Q4 2017, down 91.4% from $1.99 million a year earlier.

Analysis

Tempest Therapeutics (TPST) Asset Writedowns and Impairment (2016 - 2017) Analysis & Trends

For FY2017, Tempest Therapeutics' Asset Writedowns and Impairment was $422,000, down 78.8% from FY2016.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of 3.8% (FY2013 to FY2017).
  • Going back by year, Asset Writedowns and Impairment was $1.99 million in FY2016 and $364,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tempest Therapeutics 3.99 Mn -26.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 172,000.00
Dec 31, 2016 1.99 Mn
API Access

Tempest Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TPST&period=max&api_key=YOUR_API_KEY